U.S. markets closed

AXIM Biotechnologies, Inc. (AXIM)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.5999-0.0201 (-3.24%)
At close: 3:57PM EDT
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 4/12/2021
Current
9/30/20206/30/20203/31/2020
Market Cap (intraday) 5
81.37M79.70M34.55M8.51M
Enterprise Value 3
86.42M84.40M40.40M12.94M
Trailing P/E
N/AN/AN/AN/A
Forward P/E 1
N/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/A
Price/Sales (ttm)
77.1462.6822.3712.65
Price/Book (mrq)
35.5776.19N/AN/A
Enterprise Value/Revenue 3
108.10N/AN/A1.81k
Enterprise Value/EBITDA 7
-10.95-38.52-52.86-6.64

Trading Information

Stock Price History

Beta (5Y Monthly) 0.19
52-Week Change 3313.33%
S&P500 52-Week Change 348.80%
52 Week High 31.4400
52 Week Low 30.1200
50-Day Moving Average 30.6671
200-Day Moving Average 30.5646

Share Statistics

Avg Vol (3 month) 3310.49k
Avg Vol (10 day) 353.81k
Shares Outstanding 5125.2M
Implied Shares Outstanding 6N/A
Float 78.69M
% Held by Insiders 137.43%
% Held by Institutions 10.00%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Sep 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-832.25%

Management Effectiveness

Return on Assets (ttm)-57.34%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)799.48k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)223.79k
EBITDA -6.64M
Net Income Avi to Common (ttm)-8.27M
Diluted EPS (ttm)-0.0570
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.18M
Total Cash Per Share (mrq)0.01
Total Debt (mrq)6.29M
Total Debt/Equity (mrq)275.03
Current Ratio (mrq)1.01
Book Value Per Share (mrq)0.02

Cash Flow Statement

Operating Cash Flow (ttm)-3.98M
Levered Free Cash Flow (ttm)-2.59M